CLS Investments »

Telix Pharmaceutical Ltd Sponsored shares owned by CLS Investments

Quarter-by-quarter ownership of Telix Pharmaceutical Ltd Sponsored (TLX) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in Telix Pharmaceutical Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Telix Pharmaceutical Ltd Sponsored held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telix Pharmaceutical Ltd Sponsored by CLS Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $180k 16k 11.53

More positions owned by CLS Investments

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Ishares Tr Core S&p500 Etf (IVV)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Advisors Inner Circle Fd Ii 3edge Fixed Etf (EDGF)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Msci Total (IXUS)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for CLS Investments

Top funds holding Telix Pharmaceutical Ltd Sponsored

FMR
Lazard Asset Management
Portland Investment Counsel
Private Advisor
Marshall Wace
Integrated Wealth Concepts
Hennion & Walsh Asset Management
UBS Group
William Blair $ Company
Morgan Stanley
Raiffeisen Bank International
Quadrature Capital
Jpmorgan Chase & Co
XY Capital
XTX Topco

View all funds holding Telix Pharmaceutical Ltd Sponsored